Plasminogen Activation

Plasminogen activation refers to the enzymatic process by which the inactive zymogen plasminogen is converted into its active form, plasmin. Plasmin is a serine protease that plays a central role in fibrinolysis—the breakdown of fibrin clots—as well as in extracellular matrix remodeling and cell migration. Activation occurs when specific peptide bonds within plasminogen are cleaved—most notably at an Arg-Val site—by enzymes known as plasminogen activators, primarily tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). The activity of the system is tightly regulated by inhibitors such as PAI-1, PAI-2, protein C inhibitor, and α₂-antiplasmin. Dysregulation can lead to pathological conditions such as bleeding disorders or thrombosis. Therapeutically administered tPA is used clinically for acute thrombotic events.

Proteolytic cleavage of plasminogen to form plasmin